Federal Register / Vol. 86, No. 104 / Wednesday, June 2, 2021 / Notices 29591 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: May 26, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11518 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Implementation Cooperative Agreement (U01 

Clinical Trial Required); NIAID Clinical Trial 

Planning Grants (R34 Clinical Trial Not 

Allowed). 

Date: June 17, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F58, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Mario Cerritelli, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F58, 

Rockville, MD 20852, 240–669–5199, 

cerritem@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 26, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11546 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, June 

11, 2021, 02:30 p.m. to June 11, 2021, 

06:00 p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

May 18, 2021, 86 FR 26928. 

The CSR Special Emphasis Panel; 

RFA–RM–20–017: Harnessing Data 

Science for Health Discovery and 

Innovation in Africa—Ethical, Legal and 

Social Implications Research meeting is 

being amended to change the end time 

from 6:00 p.m. to 8:00 p.m. The meeting 

is closed to the public. 

Dated: May 26, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11520 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Detection of HIV for SelfTesting (R61/R33 Clinical Trial Not 

Allowed). 

Date: June 24, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G33B, 

Rockville, MD 20892 (Virtual Meeting), 

Contact Person: John C. Pugh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G33B, Rockville, MD 

20852, (301) 435–2398, pughjohn@

csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 26, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11545 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Exploratory Centers 

(P20) for Benign Urology. 

Date: July 20, 2021. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Lan Tian, Ph.D., Scientific 

Review Officer, National Institute of Diabetes 

and Digestive and Kidney Diseases, National 


jbell on DSKJLSW7X2PROD with NOTICES
29592 Federal Register / Vol. 86, No. 104 / Wednesday, June 2, 2021 / Notices 

Institutes of Health, Bethesda, MD 20892– 

5452, 202–821–7210 (mobile), email: tianl@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: May 26, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11515 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Allergy, Immunology, 

and Transplantation Research Committee 

(AITC). 

Date: June 24–25, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health 5601 Fishers Lane, Room 3G31, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: James T. Snyder, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G31, Bethesda, MD 

20892–9834, (240) 669–5060, james.snyder@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 26, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11543 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council, September 01, 2021, 10:00 a.m. 

to September 02, 2021, 01:45 p.m., 

National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD, 20892 which 

was published in the Federal Register 

on December 28, 2020, 85 FR 84355. 

The meeting notice is amended to 

change the date of the meeting from 

September 1–2, 2021 to September 9– 

10, 2021. The meeting is to the public. 

Dated: May 26, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11516 Filed 6–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF THE INTERIOR 

National Park Service 

[NPS–WASO–NAGPRA–31940; 

PPWOCRADN0–PCU00RP16.R50000] 

Native American Graves Protection 

and Repatriation Review Committee 

Notice of Public Meetings 

AGENCY: National Park Service, Interior. 

ACTION: Meeting notice. 

SUMMARY: The National Park Service is 

hereby giving notice that the Native 

American Graves Protection and 

Repatriation Review Committee 

(Committee) will hold six virtual 

meetings as indicated below. 

DATES: The Committee will meet via 

teleconference on June 28, 2021; July 7, 

2021; July 13, 2021; July 21, 2021; 

August 10, 2021; and August 19, 2021, 

from 3:00 p.m. until approximately 6:00 

p.m. (Eastern). All meetings are open to 

the public. 

FOR FURTHER INFORMATION CONTACT: 

Melanie O’Brien, Designated Federal 

Officer, National Native American 

Graves Protection and Repatriation Act 

(NAGPRA) Program (2253), National 

Park Service, telephone (202) 354–2201, 

or email nagpra_info@nps.gov. 

SUPPLEMENTARY INFORMATION: The 

Committee will meet virtually on June 

28, 2021; July 7, 2021; July 13, 2021; 

July 21, 2021; August 10, 2021; and 

August 19, 2021, from 3:00 p.m. until 

approximately 6:00 p.m. (Eastern). 

The agenda for each meeting may 

include a report from the National 

NAGPRA Program; the discussion of the 

Committee Report to Congress; 

subcommittee reports and discussion; 

and other topics related to the 

Committee’s responsibilities under 

section 8 of NAGPRA. In addition, the 

agenda may include requests to the 

Committee for a recommendation to the 

Secretary of the Interior that an agreedupon disposition of Native American 

human remains proceed. The meetings 

will be open to the public and there will 

be time for public comments. Written 

comments may be sent to see FOR

FURTHER INFORMATION CONTACT. All 

comments received will be provided to 

the Committee. 

Information on joining the virtual 

conference by internet or phone will be 

available on the National NAGPRA 

Program website at https://

www.nps.gov/orgs/1335/events.htm. 

Background 

The Committee was established in 

section 8 of the Native American Graves 

Protection and Repatriation Act of 1990. 

Information about NAGPRA, the 

Committee, and Committee meetings is 

available on the National NAGPRA 

Program website at https://

www.nps.gov/orgs/1335/events.htm. 

The Committee is responsible for 

monitoring the NAGPRA inventory and 

identification process; reviewing and 

making findings related to the identity 

or cultural affiliation of cultural items, 

or the return of such items; facilitating 

the resolution of disputes; compiling an 

inventory of culturally unidentifiable 

human remains that are in the 

possession or control of each Federal 

agency and museum, and 

recommending specific actions for 

developing a process for disposition of 

such human remains; consulting with 

Indian tribes and Native Hawaiian 

organizations and museums on matters 

affecting such tribes or organizations 

lying within the scope of work of the 

Committee; consulting with the 

Secretary of the Interior on the 

development of regulations to carry out 

NAGPRA; and making 

recommendations regarding future care 

of repatriated cultural items. The 

Committee’s work is carried out during 


jbell on DSKJLSW7X2PROD with NOTICES